Results 61 to 70 of about 780,904 (321)

Open-label placebo treatment in chronic low back pain: a randomized controlled trial

open access: yesPain, 2016
This randomized controlled trial was performed to investigate whether placebo effects in chronic low back pain could be harnessed ethically by adding open-label placebo (OLP) treatment to treatment as usual (TAU) for 3 weeks.
Cláudia Carvalho   +5 more
semanticscholar   +1 more source

Time trends and predictors of gout remission over six years

open access: yesArthritis Care &Research, Accepted Article.
Objectives This study aims to describe the trends in remission rates over six years of follow‐up among people with gout taking urate‐lowering therapy (ULT), and to identify variables that predict remission. Methods A post hoc analysis was conducted using data from the Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout (CARES ...
Adwoa Dansoa Tabi‐Amponsah   +5 more
wiley   +1 more source

Evaluating Low Back Pain Patients for Prolapsed Interverbral Disc in a Kenyan Teaching Hospital

open access: yesThe Annals of African Surgery, 2011
Background Accurate evaluation of low back pain is essential for its rational manage-ment. The extent of use of clinical and imaging findings in identification of prolapsed intervertebral disk varies between centers. In Kenya, the diagnostic procedure
Ongeti K, BSc, MBChB, Ogeng’o J
doaj  

Prevalence of chronic low back pain: systematic review

open access: yesRevista de Saúde Pública, 2015
OBJECTIVE To estimate worldwide prevalence of chronic low back pain according to age and sex. METHODS We consulted Medline (PubMed), LILACS and EMBASE electronic databases.
R. Meucci, A. Fassa, N. Faria
semanticscholar   +1 more source

Lived and care experiences of chronic musculoskeletal shoulder pain in Australian adults: A qualitative study

open access: yesArthritis Care &Research, Accepted Article.
Objectives Australian evidence on lived and care experiences of chronic musculoskeletal shoulder pain (CMSP), irrespective of disorder classification or disease, is limited. However, such evidence is important for person‐centred care and informing local service pathways and care guidelines or standards.
Sonia Ranelli   +8 more
wiley   +1 more source

Improvements in Health‐Related Quality of Life with Treat‐to‐Target Urate‐Lowering Therapy in Gout: A Post‐hoc Analysis of a Randomized Multicenter Trial

open access: yesArthritis Care &Research, Accepted Article.
Background While treat‐to‐target urate‐lowering therapy (ULT) is endorsed as best practice in gout management, limited data exist on its impact on health‐related quality of life (HRQoL). We assessed the impact of treat‐to‐target ULT on HRQoL among participants receiving protocolized gout care, identifying factors associated with HRQoL and HRQoL change.
Austin Barry   +16 more
wiley   +1 more source

Domains of Chronic Low Back Pain and Assessing Treatment Effectiveness: A Clinical Perspective

open access: yesPain Practice, 2019
Nonspecific chronic low back pain (CLBP) is a common clinical condition that has impacts at both the individual and societal level. Pain intensity is a primary outcome used in clinical practice to quantify the severity of CLBP and the efficacy of its ...
S. Tagliaferri   +8 more
semanticscholar   +1 more source

Low back pain

open access: yesBulletin of the World Health Organization, 2003
Low back pain is a leading cause of disability. It occurs in similar proportions in all cultures, interferes with quality of life and work performance, and is the most common reason for medical consultations.
Ehrlich George E.
doaj  

The pharmacotherapy of low back pain

open access: yesSouth African Family Practice, 2016
No abstract available.
Oppel B.W. Greeff
doaj   +1 more source

Home - About - Disclaimer - Privacy